Acquisitions (Tables)

12 Months Ended

Dec. 31, 2014

Fair Value Of Total Consideration Transferred And Major Class Of Consideration

The acquisition date fair value of the total consideration transferred and acquisition date fair value of each major class of consideration for the acquisitions completed during 2014 and 2013, including post acquisition date adjustments recorded to purchase price allocations, are as follows (in thousands):



	2014						2013
				Individual			Individual
	Sheridan ⁽¹⁾			Acquisitions ⁽¹⁾			Acquisitions
Accounts receivable	$	130,260		$	1,816		$	4,011
Other current assets	105,757			1,075			2,014
Property and equipment	20,185			3,294			6,894
Goodwill	1,534,656			101,865			116,243
Intangible assets	1,200,028			14,207			—
Other long-term assets	50,304			—			—
Accounts payable	(5,862		)	(2,519		)	(2,214		)
Other accrued liabilities	(118,548		)	(626		)	(532		)
Deferred income taxes	(432,792		)	—			—
Other long-term liabilities	(69,456		)	(8,588		)	(254		)
Long-term debt	(4,594		)	(717		)	(3,028		)
Total fair value	2,409,938			109,807			123,134
Less: Fair value attributable to noncontrolling interests	24,365			39,371			49,792
Acquisition date fair value of total consideration transferred	$	2,385,573		$	70,436		$	73,342


(1)	Represents the preliminary allocation of fair value of acquired assets and liabilities associated with these acquisitions at December 31, 2014.

Revenues And Net Earnings Associated With Acquisitions

Revenues and net earnings included in the years ended December 31, 2014 and 2013 associated with completed acquisitions are as follows (in thousands):



	2014				2013
			Individual		Individual
	Sheridan		Acquisitions		Acquisitions
Net revenues	$	517,213	$	20,844	$	15,616

Net earnings	26,776		5,155		4,596
Less: Net earnings attributable to noncontrolling interests	459		2,859		2,603
Net earnings attributable to AmSurg Corp. common shareholders	$	26,317	$	2,296	$	1,993

Consolidated Pro Forma Results Of Acquisition

The unaudited consolidated pro forma results for the years ended December 31, 2014 and 2013, assuming all 2014 acquisitions had been consummated on January 1, 2013, all 2013 acquisitions had been consummated on January 1, 2012 are as follows (in thousands):



	2014		2013
Revenues	$	2,217,682	$	2,171,999
Net earnings	295,156		243,675
Amounts attributable to AmSurg Corp. common shareholders:
Net earnings	97,538		39,980
Net earnings per common share:
Basic	$	1.88	$	0.66
Diluted	$	1.86	$	0.65